GlassScriptPhysician profile
Gabriel Belanger
NPI 1891081808
$1,706.09
in general payments reported to CMS, 2019-2025
15 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.86 · 2020: $81.84 · 2021: $83.29 · 2022: $125 · 2023: $366 · 2024: $647 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $96.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $96.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $341.95 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $253.05 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $214.23 | 2019-2024 | Xiaflex, Aveed |
| Boston Scientific Corporation | $191.23 | 2019-2025 | Lithovue, Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $183.61 | 2022-2024 | Botox |
| Ferring Pharmaceuticals INC. | $137.14 | 2024-2025 | Adstiladrin |
| Pfizer INC. | $98.60 | 2019-2024 | |
| Coloplast Corp | $53.74 | 2020 | |
| Astellas Pharma US INC | $43.29 | 2024 | |
| Progenics Pharmaceuticals, INC. | $42.36 | 2021-2025 | |
| Dentsply Ih Ab | $37.71 | 2025 | Lofric |
| Myriad Genetic Laboratories, INC. | $34.90 | 2023 | Prolaris |
| Merck Sharp & Dohme LLC | $33.83 | 2024 | Keytruda |
| Becton, Dickinson and Company | $25.20 | 2024 | Bard Urinary Drainage Bag |
| Halozyme INC | $15.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Belanger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.